TL;DR
Turn your wind-down time into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
A Monash University-led trial across 31 Australian general practices found that a 12-month nurse-led program was associated with improved estimated dementia risk profiles in middle-aged adults. The study measured risk-score changes, not dementia diagnoses or prevention; researchers plan to examine whether the changes last at 36 months.
A Monash University-led trial found that a 12-month program delivered by general practice nurses improved estimated dementia risk profiles among adults aged 45 to 65 with modifiable risk factors. Published in The Lancet Regional Health – Western Pacific, the study tested nurse consultations, personalized action plans and the HAPPI MIND app across 31 Australian practices; it measured risk scores, not whether participants developed dementia or avoided cognitive decline.
The trial included more than 403 adults. Participants in the intervention group received five consultations with a practice nurse, a custom action plan and access to an app for self-monitoring and goal tracking. The comparison group received standard risk assessment results and educational material. The study report describes the difference in estimated risk scores after 12 months as statistically significant compared with standard care.
Fifty-six percent of participants in the intervention program showed an improvement, compared with 44 percent in the comparison group. Researchers said gains in the intervention group were driven mainly by changes in protective lifestyle behaviors, including increased physical activity, improved fish intake and better body mass index status. The reported figures describe the share of participants whose profiles improved; they are not a measure of dementia cases prevented.
Senior author Associate Professor Johnson George said the approach combines support from a nurse with tools for people to track goals between appointments. Lead author Dr Muhammad Rehan Sarwar said the results suggest that personalized support in general practice may help people act on modifiable risk factors. Both framed wider use as dependent on further evaluation.
A Primary-Care Route to Risk Reduction
The results point to a possible way for primary care teams to support people who want to address modifiable factors linked to brain health. Rather than relying on written risk results alone, the program paired assessment with repeated nurse support and an app to record goals. That model may be relevant to general practices looking for structured ways to discuss lifestyle changes with middle-aged patients.
The study also reports that some changes involved behaviors and measures with potential relevance beyond dementia risk. Co-author Dr Amanda Cross said the targeted factors can also bring more immediate benefits for cardiovascular or metabolic health. That is a rationale offered by the researchers, not evidence from this trial that the program reduced those conditions or produced long-term health outcomes.
The findings do not establish that the program prevents dementia. The trial tracked estimated risk profiles over 12 months, not clinical diagnoses or cognitive decline. Its value for readers is in showing a measurable short-term change under a structured primary-care program, while leaving the durability and clinical meaning of that change to be tested.
Products Worth Considering
Withings Sleep Under-Mattress Sleep Tracking Pad
Garmin Venu 3 Fitness Smartwatch, 45 mm, Black
Oral-B iO Series 3 Rechargeable Electric Toothbrush for Adults, Black, with 2 Brush Heads and Travel Case
As an affiliate, we earn on qualifying purchases.
How the Australian Trial Worked
The study focused on adults aged 45 to 65 who had modifiable dementia risk factors and were recruited through 31 general practices in Australia. The intervention combined five nurse visits with an individualized action plan and the HAPPI MIND app. The comparison group received risk assessment information and educational material, allowing researchers to compare the additional support with standard care.
The work follows publication of the World Health Organization’s guidelines on reducing risk of cognitive decline and dementia, as well as a Monash-led update to Australia’s Clinical Practice Guidelines for Dementia, according to the report. The Australian Institute of Health and Welfare estimates that 459,000 people in Australia are living with dementia in 2026 and projects the number will exceed one million by 2066. Those figures describe the national burden and forecast; they do not indicate an effect of the nurse-led program.
“The trial measured changes in estimated risk profiles over 12 months, rather than tracking long term clinical diagnoses or preventing cognitive decline.”
— Dr Amanda Cross, co-author and senior research fellow
Long-Term Effects Still Unknown
The study does not show whether the improved scores persist, whether they translate into fewer dementia diagnoses, or whether they change cognitive outcomes. Researchers also have not yet reported the planned 36-month follow-up. The supplied report does not provide the size of the average score change, detailed statistical estimates, or enough information to assess how the program might perform at a larger scale.
The comparison group also received risk results and educational materials, so the reported difference concerns the overall nurse-led package against that form of standard care. The study does not establish which individual component—consultations, action planning or app use—accounted for the change. Broader delivery and sustained behavior change remain possibilities to evaluate, not conclusions from the 12-month results.
Researchers Plan 36-Month Follow-Up
The next stated milestone is analysis of 36-month follow-up data, which researchers say will help determine whether early improvements last. That follow-up could clarify the durability of changes in estimated risk profiles, though the source report does not specify when results will be released or whether the longer-term analysis will include clinical dementia outcomes.
Until further results are available, the findings support a short-term improvement in estimated risk profiles under the tested program, not a claim that dementia has been prevented. Any decisions about personal health risks or lifestyle changes should be discussed with a qualified health professional.
Key Questions
What did the Monash study find?
The study reported a statistically significant improvement in estimated dementia risk scores after 12 months for adults in a nurse-led program, compared with standard care. Fifty-six percent of intervention participants improved, versus 44 percent in the comparison group.
Did the program prevent dementia?
The study did not measure dementia diagnoses or whether participants avoided cognitive decline. It assessed changes in estimated risk profiles over 12 months, so it cannot establish that the program prevents dementia.
What did participants in the program receive?
Participants had five nurse consultations, a personalized action plan and access to the HAPPI MIND app for self-monitoring and goal tracking. The comparison group received standard risk assessment results and educational material.
What happens next?
Researchers plan to examine 36-month follow-up data to see whether the reported improvements last. The report does not say when those results will be published or specify whether they will track clinical diagnoses.
Source: news-medical.net
